Immunofluorescence Assay Market 2027 By Type, Product, Disease, End User and Geography | The Insight Partners

Immunofluorescence Assay Market to 2027 - Global Analysis and Forecasts By Type (Micro Immunofluorescence, Indirect Immunofluorescence, Direct Immunofluorescence); Product (Antibodies, Kits & Reagents, Labeling Dyes, Instruments); Disease (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Others); End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institute, Hospitals & Diagnostic Centers, Contract Research Organizations) and Geography

Report Code: TIPBT00002378 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Immunofluorescence is a technique used for light microscopy with a fluorescence microscope and is used primarily on microbiological samples. This technique uses the specificity of antibodies to their antigen to target fluorescent dyes to specific biomolecule targets within a cell and therefore allows visualization of the distribution of the target molecule through the sample. The specific region an antibody recognizes on an antigen is called an epitope.

MARKET DYNAMICS

The market of immunofluorescence assay is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing prevalence of chronic diseases, increasing R&D spending and growing healthcare spending. However the high rate of diagnostic kits, shortage of skilled labor and chances of cross contamination are expected to impede the market growth.

MARKET SCOPE

The "Global Immunofluorescence assay Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of immunofluorescence assay market with detailed market segmentation by type, product, disease, end user and geography. The global immunofluorescence assay market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading immunofluorescence assay market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global immunofluorescence assay market is segmented on the basis of type, product, disease and end user. Based on type, the market is segmented as micro immunofluorescence, indirect immunofluorescence and direct immunofluorescence. On the basis of product, the global immunofluorescence assay market is segmented into antibodies, kits and reagents, labeling dyes and instruments. On the basis of disease, the market is segmented into cancer, infectious diseases, cardiovascular diseases, autoimmune diseases and others. Based on end user, the market is segmented as pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic centers and contract research organizations.
REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global immunofluorescence assay market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The immunofluorescence assay market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting immunofluorescence assay market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the immunofluorescence assay market in these regions.

MARKET PLAYERS

The reports cover key developments in the immunofluorescence assay market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from immunofluorescence assay market are anticipated to lucrative growth opportunities in the future with the rising demand for immunofluorescence assay in the global market. Below mentioned is the list of few companies engaged in the immunofluorescence assay market

The report also includes the profiles of key immunofluorescence assay market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Thermo Fisher Scientific Inc.
  •  Abcam plc.
  •  Bio-Rad Laboratories, Inc.
  •  PerkinElmer Inc.
  •  Merck KGaA
  •  BD
  •  Agilent Technologies, Inc.
  •  Enzo Life Sciences, Inc.
  •  Sino Biological Inc.
  •  Danaher

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

 

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Immunofluorescence Assay Market - By Type
 1.3.2 Immunofluorescence Assay Market - By Product
 1.3.3 Immunofluorescence Assay Market - By Disease
 1.3.4 Immunofluorescence Assay Market - By End User
 1.3.5 Immunofluorescence Assay Market - By Region
 1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. IMMUNOFLUORESCENCE ASSAY MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS
5. IMMUNOFLUORESCENCE ASSAY MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. IMMUNOFLUORESCENCE ASSAY MARKET - GLOBAL MARKET ANALYSIS
 6.1. IMMUNOFLUORESCENCE ASSAY - GLOBAL MARKET OVERVIEW
 6.2. IMMUNOFLUORESCENCE ASSAY - GLOBAL MARKET AND FORECAST TO 2027
 6.3. MARKET POSITIONING/MARKET SHARE
7. IMMUNOFLUORESCENCE ASSAY MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
 7.1. OVERVIEW
 7.2. TYPE MARKET FORECASTS AND ANALYSIS
 7.3. MICRO IMMUNOFLUORESCENCE
 7.3.1. Overview
 7.3.2. Micro Immunofluorescence Market Forecast and Analysis
 7.4. INDIRECT IMMUNOFLUORESCENCE
 7.4.1. Overview
 7.4.2. Indirect Immunofluorescence Market Forecast and Analysis
 7.5. DIRECT IMMUNOFLUORESCENCE
 7.5.1. Overview
 7.5.2. Direct Immunofluorescence Market Forecast and Analysis
8. IMMUNOFLUORESCENCE ASSAY MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
 8.1. OVERVIEW
 8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
 8.3. ANTIBODIES
 8.3.1. Overview
 8.3.2. Antibodies Market Forecast and Analysis
 8.4. KITS & REAGENTS
 8.4.1. Overview
 8.4.2. Kits & Reagents Market Forecast and Analysis
 8.5. LABELING DYES
 8.5.1. Overview
 8.5.2. Labeling Dyes Market Forecast and Analysis
 8.6. INSTRUMENTS
 8.6.1. Overview
 8.6.2. Instruments Market Forecast and Analysis
9. IMMUNOFLUORESCENCE ASSAY MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE
 9.1. OVERVIEW
 9.2. DISEASE MARKET FORECASTS AND ANALYSIS
 9.3. CANCER
 9.3.1. Overview
 9.3.2. Cancer Market Forecast and Analysis
 9.4. INFECTIOUS DISEASES
 9.4.1. Overview
 9.4.2. Infectious Diseases Market Forecast and Analysis
 9.5. CARDIOVASCULAR DISEASES
 9.5.1. Overview
 9.5.2. Cardiovascular Diseases Market Forecast and Analysis
 9.6. AUTOIMMUNE DISEASES
 9.6.1. Overview
 9.6.2. Autoimmune Diseases Market Forecast and Analysis
 9.7. OTHERS
 9.7.1. Overview
 9.7.2. Others Market Forecast and Analysis
10. IMMUNOFLUORESCENCE ASSAY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
 10.1. OVERVIEW
 10.2. END USER MARKET FORECASTS AND ANALYSIS
 10.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 10.3.1. Overview
 10.3.2. Pharmaceutical & Biotechnology Companies Market Forecast and Analysis
 10.4. ACADEMIC & RESEARCH INSTITUTE
 10.4.1. Overview
 10.4.2. Academic & Research Institute Market Forecast and Analysis
 10.5. HOSPITALS & DIAGNOSTIC CENTERS
 10.5.1. Overview
 10.5.2. Hospitals & Diagnostic Centers Market Forecast and Analysis
 10.6. CONTRACT RESEARCH ORGANIZATIONS
 10.6.1. Overview
 10.6.2. Contract Research Organizations Market Forecast and Analysis
11. IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
 11.1. NORTH AMERICA
 11.1.1 North America Immunofluorescence Assay Market Overview
 11.1.2 North America Immunofluorescence Assay Market Forecasts and Analysis
 11.1.3 North America Immunofluorescence Assay Market Forecasts and Analysis - By Type
 11.1.4 North America Immunofluorescence Assay Market Forecasts and Analysis - By Product
 11.1.5 North America Immunofluorescence Assay Market Forecasts and Analysis - By Disease
 11.1.6 North America Immunofluorescence Assay Market Forecasts and Analysis - By End User
 11.1.7 North America Immunofluorescence Assay Market Forecasts and Analysis - By Countries
 11.1.7.1 United States Immunofluorescence Assay Market
 11.1.7.1.1 United States Immunofluorescence Assay Market by Type
 11.1.7.1.2 United States Immunofluorescence Assay Market by Product
 11.1.7.1.3 United States Immunofluorescence Assay Market by Disease
 11.1.7.1.4 United States Immunofluorescence Assay Market by End User
 11.1.7.2 Canada Immunofluorescence Assay Market
 11.1.7.2.1 Canada Immunofluorescence Assay Market by Type
 11.1.7.2.2 Canada Immunofluorescence Assay Market by Product
 11.1.7.2.3 Canada Immunofluorescence Assay Market by Disease
 11.1.7.2.4 Canada Immunofluorescence Assay Market by End User
 11.1.7.3 Mexico Immunofluorescence Assay Market
 11.1.7.3.1 Mexico Immunofluorescence Assay Market by Type
 11.1.7.3.2 Mexico Immunofluorescence Assay Market by Product
 11.1.7.3.3 Mexico Immunofluorescence Assay Market by Disease
 11.1.7.3.4 Mexico Immunofluorescence Assay Market by End User
 11.2. EUROPE
 11.2.1 Europe Immunofluorescence Assay Market Overview
 11.2.2 Europe Immunofluorescence Assay Market Forecasts and Analysis
 11.2.3 Europe Immunofluorescence Assay Market Forecasts and Analysis - By Type
 11.2.4 Europe Immunofluorescence Assay Market Forecasts and Analysis - By Product
 11.2.5 Europe Immunofluorescence Assay Market Forecasts and Analysis - By Disease
 11.2.6 Europe Immunofluorescence Assay Market Forecasts and Analysis - By End User
 11.2.7 Europe Immunofluorescence Assay Market Forecasts and Analysis - By Countries
 11.2.7.1 Germany Immunofluorescence Assay Market
 11.2.7.1.1 Germany Immunofluorescence Assay Market by Type
 11.2.7.1.2 Germany Immunofluorescence Assay Market by Product
 11.2.7.1.3 Germany Immunofluorescence Assay Market by Disease
 11.2.7.1.4 Germany Immunofluorescence Assay Market by End User
 11.2.7.2 France Immunofluorescence Assay Market
 11.2.7.2.1 France Immunofluorescence Assay Market by Type
 11.2.7.2.2 France Immunofluorescence Assay Market by Product
 11.2.7.2.3 France Immunofluorescence Assay Market by Disease
 11.2.7.2.4 France Immunofluorescence Assay Market by End User
 11.2.7.3 Italy Immunofluorescence Assay Market
 11.2.7.3.1 Italy Immunofluorescence Assay Market by Type
 11.2.7.3.2 Italy Immunofluorescence Assay Market by Product
 11.2.7.3.3 Italy Immunofluorescence Assay Market by Disease
 11.2.7.3.4 Italy Immunofluorescence Assay Market by End User
 11.2.7.4 Spain Immunofluorescence Assay Market
 11.2.7.4.1 Spain Immunofluorescence Assay Market by Type
 11.2.7.4.2 Spain Immunofluorescence Assay Market by Product
 11.2.7.4.3 Spain Immunofluorescence Assay Market by Disease
 11.2.7.4.4 Spain Immunofluorescence Assay Market by End User
 11.2.7.5 United Kingdom Immunofluorescence Assay Market
 11.2.7.5.1 United Kingdom Immunofluorescence Assay Market by Type
 11.2.7.5.2 United Kingdom Immunofluorescence Assay Market by Product
 11.2.7.5.3 United Kingdom Immunofluorescence Assay Market by Disease
 11.2.7.5.4 United Kingdom Immunofluorescence Assay Market by End User
 11.3. ASIA-PACIFIC
 11.3.1 Asia-Pacific Immunofluorescence Assay Market Overview
 11.3.2 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis
 11.3.3 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis - By Type
 11.3.4 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis - By Product
 11.3.5 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis - By Disease
 11.3.6 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis - By End User
 11.3.7 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis - By Countries
 11.3.7.1 Australia Immunofluorescence Assay Market
 11.3.7.1.1 Australia Immunofluorescence Assay Market by Type
 11.3.7.1.2 Australia Immunofluorescence Assay Market by Product
 11.3.7.1.3 Australia Immunofluorescence Assay Market by Disease
 11.3.7.1.4 Australia Immunofluorescence Assay Market by End User
 11.3.7.2 China Immunofluorescence Assay Market
 11.3.7.2.1 China Immunofluorescence Assay Market by Type
 11.3.7.2.2 China Immunofluorescence Assay Market by Product
 11.3.7.2.3 China Immunofluorescence Assay Market by Disease
 11.3.7.2.4 China Immunofluorescence Assay Market by End User
 11.3.7.3 India Immunofluorescence Assay Market
 11.3.7.3.1 India Immunofluorescence Assay Market by Type
 11.3.7.3.2 India Immunofluorescence Assay Market by Product
 11.3.7.3.3 India Immunofluorescence Assay Market by Disease
 11.3.7.3.4 India Immunofluorescence Assay Market by End User
 11.3.7.4 Japan Immunofluorescence Assay Market
 11.3.7.4.1 Japan Immunofluorescence Assay Market by Type
 11.3.7.4.2 Japan Immunofluorescence Assay Market by Product
 11.3.7.4.3 Japan Immunofluorescence Assay Market by Disease
 11.3.7.4.4 Japan Immunofluorescence Assay Market by End User
 11.3.7.5 South Korea Immunofluorescence Assay Market
 11.3.7.5.1 South Korea Immunofluorescence Assay Market by Type
 11.3.7.5.2 South Korea Immunofluorescence Assay Market by Product
 11.3.7.5.3 South Korea Immunofluorescence Assay Market by Disease
 11.3.7.5.4 South Korea Immunofluorescence Assay Market by End User
 11.4. MIDDLE EAST AND AFRICA
 11.4.1 Middle East and Africa Immunofluorescence Assay Market Overview
 11.4.2 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis
 11.4.3 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis - By Type
 11.4.4 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis - By Product
 11.4.5 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis - By Disease
 11.4.6 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis - By End User
 11.4.7 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis - By Countries
 11.4.7.1 South Africa Immunofluorescence Assay Market
 11.4.7.1.1 South Africa Immunofluorescence Assay Market by Type
 11.4.7.1.2 South Africa Immunofluorescence Assay Market by Product
 11.4.7.1.3 South Africa Immunofluorescence Assay Market by Disease
 11.4.7.1.4 South Africa Immunofluorescence Assay Market by End User
 11.4.7.2 Saudi Arabia Immunofluorescence Assay Market
 11.4.7.2.1 Saudi Arabia Immunofluorescence Assay Market by Type
 11.4.7.2.2 Saudi Arabia Immunofluorescence Assay Market by Product
 11.4.7.2.3 Saudi Arabia Immunofluorescence Assay Market by Disease
 11.4.7.2.4 Saudi Arabia Immunofluorescence Assay Market by End User
 11.4.7.3 U.A.E Immunofluorescence Assay Market
 11.4.7.3.1 U.A.E Immunofluorescence Assay Market by Type
 11.4.7.3.2 U.A.E Immunofluorescence Assay Market by Product
 11.4.7.3.3 U.A.E Immunofluorescence Assay Market by Disease
 11.4.7.3.4 U.A.E Immunofluorescence Assay Market by End User
 11.5. SOUTH AND CENTRAL AMERICA
 11.5.1 South and Central America Immunofluorescence Assay Market Overview
 11.5.2 South and Central America Immunofluorescence Assay Market Forecasts and Analysis
 11.5.3 South and Central America Immunofluorescence Assay Market Forecasts and Analysis - By Type
 11.5.4 South and Central America Immunofluorescence Assay Market Forecasts and Analysis - By Product
 11.5.5 South and Central America Immunofluorescence Assay Market Forecasts and Analysis - By Disease
 11.5.6 South and Central America Immunofluorescence Assay Market Forecasts and Analysis - By End User
 11.5.7 South and Central America Immunofluorescence Assay Market Forecasts and Analysis - By Countries
 11.5.7.1 Brazil Immunofluorescence Assay Market
 11.5.7.1.1 Brazil Immunofluorescence Assay Market by Type
 11.5.7.1.2 Brazil Immunofluorescence Assay Market by Product
 11.5.7.1.3 Brazil Immunofluorescence Assay Market by Disease
 11.5.7.1.4 Brazil Immunofluorescence Assay Market by End User
 11.5.7.2 Argentina Immunofluorescence Assay Market
 11.5.7.2.1 Argentina Immunofluorescence Assay Market by Type
 11.5.7.2.2 Argentina Immunofluorescence Assay Market by Product
 11.5.7.2.3 Argentina Immunofluorescence Assay Market by Disease
 11.5.7.2.4 Argentina Immunofluorescence Assay Market by End User
12. INDUSTRY LANDSCAPE
 12.1. MERGERS AND ACQUISITIONS
 12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 12.3. NEW PRODUCT LAUNCHES
 12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. IMMUNOFLUORESCENCE ASSAY MARKET, KEY COMPANY PROFILES
 13.1. THERMO FISHER SCIENTIFIC INC.
 13.1.1. Key Facts
 13.1.2. Business Description
 13.1.3. Products and Services
 13.1.4. Financial Overview
 13.1.5. SWOT Analysis
 13.1.6. Key Developments
 13.2. ABCAM PLC.
 13.2.1. Key Facts
 13.2.2. Business Description
 13.2.3. Products and Services
 13.2.4. Financial Overview
 13.2.5. SWOT Analysis
 13.2.6. Key Developments
 13.3. BIO-RAD LABORATORIES, INC.
 13.3.1. Key Facts
 13.3.2. Business Description
 13.3.3. Products and Services
 13.3.4. Financial Overview
 13.3.5. SWOT Analysis
 13.3.6. Key Developments
 13.4. PERKINELMER INC.
 13.4.1. Key Facts
 13.4.2. Business Description
 13.4.3. Products and Services
 13.4.4. Financial Overview
 13.4.5. SWOT Analysis
 13.4.6. Key Developments
 13.5. MERCK KGAA
 13.5.1. Key Facts
 13.5.2. Business Description
 13.5.3. Products and Services
 13.5.4. Financial Overview
 13.5.5. SWOT Analysis
 13.5.6. Key Developments
 13.6. BD
 13.6.1. Key Facts
 13.6.2. Business Description
 13.6.3. Products and Services
 13.6.4. Financial Overview
 13.6.5. SWOT Analysis
 13.6.6. Key Developments
 13.7. AGILENT TECHNOLOGIES, INC.
 13.7.1. Key Facts
 13.7.2. Business Description
 13.7.3. Products and Services
 13.7.4. Financial Overview
 13.7.5. SWOT Analysis
 13.7.6. Key Developments
 13.8. ENZO LIFE SCIENCES, INC.
 13.8.1. Key Facts
 13.8.2. Business Description
 13.8.3. Products and Services
 13.8.4. Financial Overview
 13.8.5. SWOT Analysis
 13.8.6. Key Developments
 13.9. SINO BIOLOGICAL INC.
 13.9.1. Key Facts
 13.9.2. Business Description
 13.9.3. Products and Services
 13.9.4. Financial Overview
 13.9.5. SWOT Analysis
 13.9.6. Key Developments
 13.10. DANAHER.
 13.10.1. Key Facts
 13.10.2. Business Description
 13.10.3. Products and Services
 13.10.4. Financial Overview
 13.10.5. SWOT Analysis
 13.10.6. Key Developments
14. APPENDIX
 14.1. ABOUT THE INSIGHT PARTNERS
 14.2. GLOSSARY OF TERMS

 

The List of Companies

1. Thermo Fisher Scientific Inc.
2. Abcam plc.
3. Bio-Rad Laboratories, Inc.
4. PerkinElmer Inc.
5. Merck KGaA
6. BD
7. Agilent Technologies, Inc.
8. Enzo Life Sciences, Inc.
9. Sino Biological Inc.
10. Danaher